Astrea Bioseparations, a provider of bio separation and purification technologies expanded its manufacturing and warehousing capabilities in the U.S. The increased capacity reflects growing demand for the company’s chromatography solutions in North American markets. In a statement, the company said that the new, 12,000 sq. ft. facility will allow Astrea Bio to bring its products to customers within lead times of 3-5 weeks for off-the-shelf products, and 6-8 weeks for large-scale resin orders....